{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:19:10Z","timestamp":1785424750467,"version":"3.56.0"},"reference-count":40,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["22001133"],"award-info":[{"award-number":["22001133"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473840"],"award-info":[{"award-number":["82473840"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"award":["22001133"],"award-info":[{"award-number":["22001133"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"award":["82473840"],"award-info":[{"award-number":["82473840"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"publisher"}]},{"name":"Key Natural Science Foundation of Jiangsu Higher Education Institutions","award":["20KJA350002"],"award-info":[{"award-number":["20KJA350002"]}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX25_3844"],"award-info":[{"award-number":["KYCX25_3844"]}]},{"name":"large instruments open foundation of Nantong University","award":["KFJN2270"],"award-info":[{"award-number":["KFJN2270"]}]},{"name":"large instruments open foundation of Nantong University","award":["KFJN2367"],"award-info":[{"award-number":["KFJN2367"]}]},{"award":["KFJN2270"],"award-info":[{"award-number":["KFJN2270"]}],"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}]},{"award":["KFJN2367"],"award-info":[{"award-number":["KFJN2367"]}],"id":[{"id":"https:\/\/ror.org\/02afcvw97","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Photodynamic therapy (PDT) represents a highly promising modality for cancer treatment; however, its clinical success is significantly restricted by the hypoxic nature of the tumor microenvironment (TME). Hypoxia also upregulates hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1) expression, thereby exacerbating tumor malignancy. To tackle this challenge, we engineered a hypoxia-activatable supramolecular nanoplatform (GH@CyNPs) capable of dual hypoxia reversal and amplification of PDT efficacy. The nanoplatform was constructed via host\u2013guest interactions between a water-soluble pillar[5]arene (WP5) and an azobenzene-linked cyanine\/YC-1 conjugate (Cy-G), followed by the co-encapsulation of glucose oxidase (GOx) and catalase (CAT). Upon entering the cancer cells via endocytosis, the azobenzene linker is specifically cleaved by the hypoxic TME, facilitating payload release. Concurrently, the released GOx\/CAT pair drives in situ cascade reactions to generate oxygen (O2), while YC-1 effectively suppresses HIF-1\u03b1 expression, thereby achieving synergistic alleviation of hypoxia. Under irradiation, the released cyanine acts as a potent photosensitizer, generating abundant reactive oxygen species (ROS) to kill cancer cells. Both in vitro and in vivo evaluations corroborated that GH@CyNPs exhibit preferential tumor accumulation, profound antitumor efficacy, and excellent biocompatibility. This study presents an innovative paradigm for overcoming TME hypoxia to optimize photodynamic oncotherapy.<\/jats:p>","DOI":"10.3390\/molecules31142433","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:05:31Z","timestamp":1783929931000},"page":"2433","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a Hypoxia-Triggered Supramolecular Nanoplatform for Synergistic Hypoxia Alleviation and Amplified Photodynamic Cancer Therapy"],"prefix":"10.3390","volume":"31","author":[{"given":"Ningning","family":"Luo","sequence":"first","affiliation":[{"name":"Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiliang","family":"Wu","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Zheng","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Qian","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caoqing","family":"Ji","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiqing","family":"Jiang","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University, Nanjing 210093, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Ling","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[{"name":"Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, School of Pharmacy, Nantong University, Nantong 226001, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41392-023-01536-y","article-title":"Nanomedicine in cancer therapy","volume":"8","author":"Fan","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_2","first-page":"769","article-title":"Paclitaxel anti-cancer therapeutics: From discovery to clinical use","volume":"23","author":"Yu","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12672-025-02198-8","article-title":"Advancements and limitations in traditional anti-cancer therapies: A comprehensive review of surgery, chemotherapy, radiation therapy, and hormonal therapy","volume":"16","author":"Zafar","year":"2025","journal-title":"Discov. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1021\/acs.molpharmaceut.4c01046","article-title":"Novel Ru(II) complexes as typeI\/II photosensitizers for multimodal hypoxia-tolerant chemo-photodynamic\/immune therapy","volume":"22","author":"Liu","year":"2025","journal-title":"Mol. Pharm."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.2147\/IJN.S359156","article-title":"Combined prussian blue nanozyme carriers improve photodynamic therapy and effective interruption of tumor metastasis","volume":"17","author":"Shen","year":"2022","journal-title":"Int. J. Nanomed."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Algorri, J.F., Ochoa, M., Rold\u00e1n-Varona, P., Rodr\u00edguez-Cobo, L., and L\u00f3pez-Higuera, J.M. (2021). Light technology for efficient and effective photodynamic therapy: A critical review. Cancers, 13.","DOI":"10.3390\/cancers13143484"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1039\/C9TB02752A","article-title":"Light-assisted gadofullerene nanoparticles disrupt tumor vasculatures for potent melanoma treatment","volume":"8","author":"Lu","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e202404395","DOI":"10.1002\/anie.202404395","article-title":"A light-triggered j-aggregation-regulated therapy conversion: From photodynamic\/photothermal therapy to long-lasting chemodynamic therapy for effective tumor ablation","volume":"63","author":"Wei","year":"2024","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Zou, Y., Wu, J., Zhang, Q., Chen, J., Luo, X., Qu, Y., Xia, R., Wang, W., and Zheng, X. (2024). Recent advances in cell membrane-coated porphyrin-based nanoscale mofs for enhanced photodynamic therapy. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1505212"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2103978","DOI":"10.1002\/adma.202103978","article-title":"Conquering the hypoxia limitation for photodynamic therapy","volume":"33","author":"Wan","year":"2021","journal-title":"Adv. Mater."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1186\/s12951-021-01196-6","article-title":"Mitochondria-targeted nanoplatforms for enhanced photodynamic therapy against hypoxia tumor","volume":"19","author":"Wen","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"148463","DOI":"10.1016\/j.ijbiomac.2025.148463","article-title":"Reversal of hypoxia-induced chemoresistance using hemoglobin-loaded polycaprolactone nanoparticles","volume":"332","author":"Gandhi","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e02490","DOI":"10.1002\/adhm.202502490","article-title":"Bifunctional katg-mimic activity of nanosheet for coupled catalytic therapy of hypoxic tumor","volume":"14","author":"Jiang","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jcis.2024.07.113","article-title":"pH-responsive oxygen self-sufficient smart nanoplatform for enhanced tumor chemotherapy and photodynamic therapy","volume":"675","author":"Liu","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"7543","DOI":"10.1021\/jacs.3c13501","article-title":"Hypoxia reversion by low-immunogenic ultra-acid-sensitive comicelles of protein\u2013polymer conjugates sensitizes tumors to photodynamic therapy","volume":"146","author":"Huang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"107050","DOI":"10.1016\/j.jddst.2025.107050","article-title":"Navigating tumor microenvironment with time-responsive nanocarriers: Strategies for targeted drug delivery in solid tumor","volume":"110","author":"Rajankar","year":"2025","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.gendis.2023.02.039","article-title":"HIF-1\u03b1 signaling: Essential roles in tumorigenesis and implications in targeted therapies","volume":"11","author":"Zhao","year":"2024","journal-title":"Genes Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1089\/ars.2019.7935","article-title":"Targeting hypoxia-inducible factor-1-mediated metastasis for cancer therapy","volume":"34","author":"Ma","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cpt.2025.07.003","article-title":"Investigating hypoxia-inducible factor signaling in cancer: Mechanisms, clinical implications, targeted therapeutic strategies, and resistance","volume":"4","author":"Shaikat","year":"2026","journal-title":"Cancer Pathog. Ther."},{"key":"ref_20","first-page":"572","article-title":"Salidroside inhibits osteoclast differentiation based on osteoblast-osteoclast interaction via HIF-1\u03b1 pathway","volume":"23","author":"Jin","year":"2025","journal-title":"Chin. J. Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"20875","DOI":"10.1021\/acsnano.3c07763","article-title":"Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment","volume":"17","author":"Pan","year":"2023","journal-title":"ACS Nano"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113745","DOI":"10.1016\/j.jconrel.2025.113745","article-title":"Reversing hypoxia-induced immune evasion in tumors to enhance cancer immunotherapy","volume":"382","author":"Sun","year":"2025","journal-title":"J. Control. Release"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"106400","DOI":"10.1016\/j.bioorg.2023.106400","article-title":"Advances in antitumor research of HIF-1\u03b1 inhibitor YC-1 and its derivatives","volume":"133","author":"Ouyang","year":"2023","journal-title":"Bioorg. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"25795","DOI":"10.1021\/acsnano.4c08574","article-title":"Engineering biodegradable hollow silica\/iron composite nanozymes for breast tumor treatment through activation of the \u201cferroptosis storm\u201d","volume":"18","author":"Xue","year":"2024","journal-title":"ACS Nano"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"12653","DOI":"10.1038\/s41598-017-12929-9","article-title":"Low-dose YC-1 combined with glucose and insulin selectively induces apoptosis in hypoxic gastric carcinoma cells by inhibiting anaerobic glycolysis","volume":"7","author":"Wakiyama","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.oraloncology.2009.04.005","article-title":"Using YC-1 to overcome the radioresistance of hypoxic cancer cells","volume":"45","author":"Moon","year":"2009","journal-title":"Oral Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"8999","DOI":"10.1002\/adfm.201601770","article-title":"Fabrication of a targeted drug delivery system from a pillar[5]arene-based supramolecular diblock copolymeric amphiphile for effective cancer therapy","volume":"26","author":"Yu","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Li, X., Jin, Y., Zhu, N., and Jin, L.Y. (2023). Applications of supramolecular polymers generated from pillar[n]arene-based molecules. Polymers, 15.","DOI":"10.3390\/polym15234543"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"117322","DOI":"10.1016\/j.bios.2025.117322","article-title":"Supramolecular nanoagent as a dual-blocked thermoresistance inhibitor for effective mild-temperature photothermal therapy","volume":"278","author":"Liu","year":"2025","journal-title":"Biosens. Bioelectron."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2308493","DOI":"10.1002\/advs.202308493","article-title":"Supramolecular chiral binding affinity-achieved efficient synergistic cancer therapy","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jconrel.2024.06.016","article-title":"Hybrid nanopotentiators with dual cascade amplification for glioma combined interventional therapy","volume":"372","author":"Ye","year":"2024","journal-title":"J. Control. Release"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13741","DOI":"10.2147\/IJN.S556295","article-title":"Cofe2o4-based multifunctional nanozymes remodel tumor redox balance for enhanced osteosarcoma treatment","volume":"20","author":"Yang","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7155","DOI":"10.1016\/j.cell.2025.11.002","article-title":"Innate immune and metabolic signals induce mitochondria-dependent membrane lysis via mitoxyperiosis","volume":"188","author":"Wang","year":"2025","journal-title":"Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/s41401-020-0476-5","article-title":"Mitochondrial Ca2+ regulation in the etiology of heart failure: Physiological and pathophysiological implications","volume":"41","author":"Xu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"5563","DOI":"10.1038\/s41467-025-60596-6","article-title":"Self-organizing glycolytic waves tune cellular metabolic states and fuel cancer progression","volume":"16","author":"Zhan","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41401-020-0490-7","article-title":"Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation","volume":"42","author":"Song","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/s41392-026-02656-x","article-title":"Hypoxia-driven microrna-27b underlies pathologic cardiac endoreplication in heart disease","volume":"11","author":"Mirtschink","year":"2026","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41419-020-2649-z","article-title":"Mitochondria in skin health, aging, and disease","volume":"11","author":"Sreedhar","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1021\/acsnano.1c06777","article-title":"Peroxidase-like active nanomedicine with dual glutathione depletion property to restore oxaliplatin chemosensitivity and promote programmed cell death","volume":"16","author":"Wu","year":"2022","journal-title":"ACS Nano"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"113524","DOI":"10.1016\/j.biopha.2022.113524","article-title":"Ferroptosis in colorectal cancer: Potential mechanisms and effective therapeutic targets","volume":"153","author":"Wang","year":"2022","journal-title":"Biomed. Pharmacother."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/14\/2433\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T04:14:27Z","timestamp":1784002467000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/31\/14\/2433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":40,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["molecules31142433"],"URL":"https:\/\/doi.org\/10.3390\/molecules31142433","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}